EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chrysotoxine Attenuates Key Atherogenic Processes via Antioxidant, Anti-Inflammatory, and COX-Dependent Antiplatelet Mechanisms

Fozia Rustamani iD, Hla Nu Swe iD, Su Wutyi Thant iD, Jeeradej Moonrut, Boonchoo Sritularak iD, Ponlapat Rojnuckarin iD, Nonthaneth Nalinratana, Rataya Luechapudiporn iD

Biomolecules · 03.03.2026 · 16 (3) · 379

DOI: 10.3390/biom16030379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 03.03.2026. Verfasst von Fozia Rustamani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences and Technology Program, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand. Hauptthemen laut MEDLINE: Atherosclerosis, Antioxidants, Anti-Inflammatory Agents, Platelet Aggregation Inhibitors. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thailand Science Research and Innovation Fund Chulalongkorn University, 90th Anniversary of Chulalongkorn University Scholarship under Ratchadaphisek Somphot Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is a complex vascular disorder driven by oxidative stress, inflammation, and platelet activation. Agents capable of targeting multiple atherogenic pathways may provide improved therapeutic benefits. In this study, we evaluated the anti-atherogenic effects of chrysotoxine, a bibenzyl compound isolated from Dendrobium pulchellum, using in vitro models relevant to atherogenesis. Chrysotoxine significantly suppressed hemin-induced LDL oxidation by reducing lipid peroxidation and apolipoprotein modification. In an endothelial–monocyte co-culture model, chrysotoxine markedly attenuated lipopolysaccharide-induced monocyte adhesion, indicating inhibition of endothelial inflammatory activation. Chrysotoxine also inhibited platelet aggregation induced by arachidonic acid, ADP, and collagen in a concentration-dependent manner, with the strongest effects observed against arachidonic acid–mediated responses, suggesting modulation of the thromboxane pathway. Molecular docking analyses and cyclooxygenase activity assays further indicated that chrysotoxine may interact with both COX-1 and COX-2, exhibiting inhibitory activity in the low micromolar range. Collectively, these findings demonstrate that chrysotoxine modulates multiple key processes involved in atherogenesis, including oxidative LDL modification, vascular inflammation, and platelet activation. Although further in vivo studies are required, chrysotoxine represents a promising plant-derived candidate for the development of multi-target strategies against atherosclerotic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisAntioxidantsAnti-Inflammatory AgentsPlatelet Aggregation InhibitorsHumansPlatelet AggregationMolecular Docking SimulationLipoproteins, LDLLipid PeroxidationCyclooxygenase 2Oxidative StressMonocytesCyclooxygenase 1

Stichwörter der Autor:innen

LDL oxidationatherosclerosischrysotoxinecyclooxygenase (COX)platelet activationvascular inflammation

Substanzen

AntioxidantsAnti-Inflammatory AgentsPlatelet Aggregation InhibitorsLipoproteins, LDLCyclooxygenase 2Cyclooxygenase 1

Autor:innen und Institutionen

  • Pharmaceutical Sciences and Technology Program, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
  • Interdisciplinary Program in Pharmacology, Graduate School, Chulalongkorn University, Bangkok 10330, Thailand.
  • Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
  • Center of Excellence in Natural Products for Ageing and Chronic Diseases, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
  • Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
  • Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.

ORCID-Profile: Fozia Rustamani, Hla Nu Swe, Su Wutyi Thant, Boonchoo Sritularak, Ponlapat Rojnuckarin, Rataya Luechapudiporn

Förderung

  • Thailand Science Research and Innovation Fund Chulalongkorn University
  • 90th Anniversary of Chulalongkorn University Scholarship under Ratchadaphisek Somphot Fund

Zitieren

APA

Rustamani, F., Swe, H. N., Thant, S. W., Moonrut, J., Sritularak, B., Rojnuckarin, P., Nalinratana, N., & Luechapudiporn, R. (2026). Chrysotoxine Attenuates Key Atherogenic Processes via Antioxidant, Anti-Inflammatory, and COX-Dependent Antiplatelet Mechanisms. Biomolecules, 16(3), 379. https://doi.org/10.3390/biom16030379

Vancouver

Rustamani F, Swe HN, Thant SW, Moonrut J, Sritularak B, Rojnuckarin P, et al. Chrysotoxine Attenuates Key Atherogenic Processes via Antioxidant, Anti-Inflammatory, and COX-Dependent Antiplatelet Mechanisms. Biomolecules. 2026;16(3):379. doi:10.3390/biom16030379

BibTeX
@article{Rustamani2026,
  author = {Rustamani, Fozia and Swe, Hla Nu and Thant, Su Wutyi and Moonrut, Jeeradej and Sritularak, Boonchoo and Rojnuckarin, Ponlapat and Nalinratana, Nonthaneth and Luechapudiporn, Rataya},
  title = {Chrysotoxine Attenuates Key Atherogenic Processes via Antioxidant, Anti-Inflammatory, and COX-Dependent Antiplatelet Mechanisms},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {379},
  doi = {10.3390/biom16030379}
}
Kostenlos starten →